Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ivan B. Cheglakov"'
Publikováno v:
The Journal of Gene Medicine. 18:220-233
Background The combination of stem cell-based gene therapy with chemotherapy comprises an advantageous strategy that results in a reduction of system toxicity effects and an improvement in the general efficacy of treatment. In the present study, we e
Publikováno v:
The journal of gene medicine. 18(9)
The combination of stem cell-based gene therapy with chemotherapy comprises an advantageous strategy that results in a reduction of system toxicity effects and an improvement in the general efficacy of treatment. In the present study, we estimated th
Autor:
Georgy B. Telegin, Ivan B. Cheglakov, Sergey A. Kozin, Alexander Morozov, Philipp O. Tsvetkov, Oleg Mediannikov, Armen A. Ovsepyan
Publikováno v:
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, IOS Press, 2016, pp.20-20. ⟨10.3233/JAD-150031⟩
Journal of Alzheimer's Disease, IOS Press, 2016, pp.20-20. ⟨10.3233/JAD-150031⟩
International audience; Two tetrapeptides, HAEE and RADD, which are ionic-complementary to the primary zinc recognition site of amyloid-(A), have been reported to inhibit zinc-induced dimerization of the A metal-binding domain and slow A aggregation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b96531029fabe6eac5eac9353d41c3b6
https://doi.org/10.3233/JAD-150031
https://doi.org/10.3233/JAD-150031
Autor:
Armen A. Ovsepyan, G. B. Telegin, Alexander A. Makarov, Philippe O. Tsvetkov, Ivan B. Cheglakov, Sergey A. Kozin, Andrey Lisitsa
Publikováno v:
Alzheimer's & Dementia. 9
Publikováno v:
Cardiovascular drugs and therapy. 9(6)
The goal of the present study was to evaluate if mibefradil, a novel nondihydropyridine Ca2+ antagonist, could block receptor-operated calcium channels (ROCC) present in human platelets and to determine the functional consequences of this blockade. T
Publikováno v:
European journal of biochemistry. 198(1)
To elucidate the mechanism of the receptor-stimulated Ca2+ entry into human platelets, the influence of Ca(2+)-mobilizing agonists on plasma membrane potential (Em) has been studied. Em changes were registered using potentiometric probe 3,3'-dipropyl